In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes

References

• Ericsson T, Sundell J, Torkelsson A, Hoffmann KJ, Ashton M. 2014. Effects of artemisinin antimalarials on cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica. 44:615–626.
   PubMed Web of Science ®Google Scholar
• Grimm SW, Einolf HJ, Hall SD, He K, Lim HK, Ling KH, Lu C, Nomeir AA, Seibert E, Skordos KW, et al. 2009. The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos. 37:1355–1370.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang W, Yang Y. 2015. Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus Cnidii. Eur J Drug Metab Pharmacokinet. 40:373–377.
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. 1998. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol. 38:461–499.
   PubMed Web of Science ®Google Scholar
• Jeong HU, Kong TY, Kwon SS, Hong SW, Yeon SH, Choi JH, Lee JY, Cho YY, Lee HS. 2013. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules (Basel, Switzerland). 18:10681–10693.
   PubMed Web of Science ®Google Scholar
• Lang J, Li W, Zhao J, Wang K, Chen D. 2016. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica. 47:849–855.
   Web of Science ®Google Scholar
• Lee JA, Ha SK, Kim YC, Choi I. 2017. Effects of Friedelin on the intestinal permeability and bioavailability of apigenin. Pharmacol Rep. 69:1044–1048.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kang W, Kwon KI, Park SK, Oh SJ, Ma JY, Kim SK. 2013. Cytochrome P450-mediated herb–drug interaction potential of Galgeun-tang. Food Chem Toxicol. 51:343–349.
   PubMed Web of Science ®Google Scholar
• Li AP. 2001. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today. 6:357–366.
   PubMed Web of Science ®Google Scholar
• Liu T, Qian G, Wang W, Zhang Y. 2015. Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug–drug interaction with ketoconazole. Eur J Drug Metab Pharmacokinet. 40:235–238.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu K. 2014. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab. 15:791–807.
   PubMed Web of Science ®Google Scholar
• Nowack R. 2008. Review article: cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!. Nephrology (Carlton). 13:337–347.
   PubMed Web of Science ®Google Scholar
• Pandit S, Mukherjee PK, Ponnusankar S, Venkatesh M, Srikanth N. 2011. Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia. 82:369–374.
   PubMed Web of Science ®Google Scholar
• Paul J, Gnanam R, Jayadeepa RM, Arul L. 2013. Anticancer activity on Graviola, an exciting medicinal plant extract vs. various cancer cell lines and a detailed computational study on its potent anti-cancerous leads. Curr Top Med Chem. 13:1666–1673.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu H, Zhang X, Zhang F, Qi H, Zhong Y, Wang Y, Sang H, Wang G, Sun J. 2015. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug–drug interaction evaluation. Xenobiotica 45:961–977.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Tomoo T. 1994. Anti-inflammatory constituents of topically applied crude drugs. V. Constituents and anti-inflammatory effect of Aoki, Aucuba japonica Thunb. Biol Pharm Bull. 17:665–667.
   PubMed Web of Science ®Google Scholar
• Susanti D, Amiroudine MZ, Rezali MF, Taher M. 2013. Friedelin and lanosterol from Garcinia prainiana stimulated glucose uptake and adipocytes differentiation in 3T3–L1 adipocytes. Nat Prod Res. 27:417–424.
   PubMed Web of Science ®Google Scholar
• Utami R, Khalid N, Sukari MA, Rahmani M, Abdul AB. Dachriyanus 2013. Phenolic contents, antioxidant and cytotoxic activities of Elaeocarpus floribundus Blume. Pak J Pharm Sci. 26:245–250.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 22:1–21.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. 2001. Metabolism profiling, and cytochrome P450 inhibition and induction in drug discovery. Curr Top Med Chem. 1:403–425.
   PubMedGoogle Scholar
• Zhang H, Ya G, Rui H. 2017. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42:89–98.
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10:496–503.
   PubMed Web of Science ®Google Scholar
• Zhou SF. 2008. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 9:310–322.
   PubMed Web of Science ®Google Scholar